^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

U16

i
Other names: U16, CD20 specific CAR T, CART-20, CAR T-20, U 16, U-16
Associations
Company:
Central South University, Shanghai Unicar
Drug class:
CD20-targeted CAR-T immunotherapy
Associations
over1year
Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (clinicaltrials.gov)
P1/2, N=100, Recruiting, Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
New P1/2 trial
|
IL6 (Interleukin 6)
|
CD20 positive • CD20 negative
|
cyclophosphamide • U16
2years
Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma. (PubMed, Discov Oncol)
The effective dose of CAR-T20 in mice starts from 1 × 10 per mouse, equivalent to a clinical dose of 5 × 10/kg. Together, our data support the clinical translation of CAR-T20 for R/R B-cell NHL patients.
Preclinical • Journal • CAR T-Cell Therapy
|
CD20 (Membrane Spanning 4-Domains A1) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
|
CD20 expression
|
U16